Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Jul 04, 2017 5:08pm

240 Views

Post# 26433050

RE:All 3 low-dose patients have functional bladders

Hi bencro;

Yes, it does bode well for the high dose patients. However, I hope that I misread or misunderstood a post that I had read yesterday. I believe that it had stated that if it turns out that the higher dose is the more beneficial dose, the first three patients will not be retreated. This seems to be a very harsh stance. Wishing for the best results for our pioneering patients.

As always, thank you for your efforts to provide knowledge and understanding to this board.

Thanks;

made2last

Bullboard Posts

Cloud DX sells subsidiary, completes first stage of restructuring